{"id":16964,"date":"2020-10-15T10:21:02","date_gmt":"2020-10-15T14:21:02","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16964"},"modified":"2020-10-15T10:21:02","modified_gmt":"2020-10-15T14:21:02","slug":"first-of-its-kind-examination-shows-how-widely-pharma-showers-campaign-cash-at-the-state-level","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16964","title":{"rendered":"First-of-its-kind examination shows how widely pharma showers campaign cash at the state level"},"content":{"rendered":"<p>(By Lev Facher for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap-wrap\"><span class=\"big-cap\">B<\/span><\/span>y the time Will Guzzardi, a state legislator in Illinois, called a vote on his controversial drug pricing reform bill, the crowd in the Springfield hearing room had suspiciously thinned. Three committee Democrats were suddenly missing, and, as a result, his bill failed by three votes.\u00a0 Continue reading article <a href=\"https:\/\/www.statnews.com\/feature\/prescription-politics\/state-level-examination\/\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Lev Facher for STAT) By the time Will Guzzardi, a state legislator in Illinois, called a vote on his<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35,21,15],"tags":[],"class_list":["post-16964","post","type-post","status-publish","format-standard","hentry","category-elections-healthcare-issues","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16964"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16964\/revisions"}],"predecessor-version":[{"id":16965,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16964\/revisions\/16965"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}